Iovance Biotherapeutics Inc (NAS:IOVA)
$ 7.78 -0.36 (-4.42%) Market Cap: 2.18 Bil Enterprise Value: 2.01 Bil PE Ratio: 0 PB Ratio: 3.20 GF Score: 35/100

Q1 2019 Iovance Biotherapeutics Inc Earnings Call Transcript

May 07, 2019 / 08:30PM GMT
Release Date Price: $11.01 (-3.93%)
Operator

Good afternoon, and welcome to the Iovance Biotherapeutics First Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that the call is being recorded at the company's request.

Now I would like to turn the conference over to Tim Morris, Chief Financial Officer of -- at Iovance. Sir, please go ahead.

Timothy E. Morris
Iovance Biotherapeutics, Inc. - CFO, Principal Accounting Officer, Corporate Secretary & Treasurer

Thank you, Angela. Good afternoon, everyone, and thank you for joining us today. With me on the call is Kelly DiTrapani, Vice President of Medical Affairs; and Michael Swartzburg, Vice President of Finance. We'd like to note that Maria Fardis, our Executive Officer, is unfortunately unavailable to participate in today's call due to a last-minute trip involving the health of a relative, and we are extending our well wishes to her and her family at this time. This afternoon, we issued a press release that you can find on our website at iovance.com, which includes financial results for the first quarter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot